Alpha Teknova, Inc. Announces the Retirement of Ted Davis as a Member of the Board of Directors
July 01, 2024 at 04:39 pm EDT
Share
On June 26, 2024, Ted Davis, a member of the Board of Directors of Alpha Teknova, Inc. (the ?Company?), notified the Company of his intention to retire from the Company?s Board of Directors (the ?Board?). Mr. Davis informed the Company that his decision to retire is due to his other personal and professional interests and does not arise from any disagreement with the Board or the Company on any matter relating to the Company's operations, policies, or practices or any issue impacting the Board. With effect on June 28, 2024, the Board, upon the recommendation of the Nominating and Corporate Governance Committee, adopted a resolution by unanimous written consent decreasing the number of directors on the Company's Board from nine to eight and the number of Class I directors from three to two, taking account of Mr. Davis's retirement from the Board.
Alpha Teknova, Inc. is a producer of critical reagents for the research, discovery, development, and commercialization of therapies, vaccines, and molecular diagnostics. It offers two primary business lines, which include lab essentials and clinical solutions. It also offers three primary product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. The Company offers its liquid cell culture media and supplements and molecular biology reagents in both of its two product categories; pre-poured media plates are available in its Lab Essentials category only. Its customers include pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostics franchises, and academic and government research institutions developing vaccines and therapies and performing basic research.
ALPHA TEKNOVA, INC. 
